San Diego-centered Viking Therapeutics marked alone as a serious competitor during the weight loss drug current market in February soon after revealing promising info from the mid-stage demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when given like a weekly injection As well as in March the